Therapeutic applications of mesenchymal stem cells: current outlook (Q38458212)

3 September 2017

title

Therapeutic applications of mesenchymal stem cells: current outlook (English)

1 reference

3 September 2017

main subject

mesenchymal stem cell

1 reference

based on heuristic

inferred from title

author name string

Siddaraju V Boregowda

series ordinal

1

1 reference

3 September 2017

Donald G Phinney

series ordinal

2

1 reference

3 September 2017

publication date

1 August 2012

1 reference

3 September 2017

1 reference

3 September 2017

volume

26

1 reference

3 September 2017

issue

4

1 reference

3 September 2017

page(s)

201-208

1 reference

Human adipose tissue is a source of multipotent stem cells

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Isolation of an adult mouse lung mesenchymal progenitor cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

SHED: stem cells from human exfoliated deciduous teeth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Biochemical heterogeneity of mesenchymal stem cell populations: clues to their therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Bone marrow stromal stem cells: nature, biology, and potential applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Reduced reactivation from dormancy but maintained lineage choice of human mesenchymal stem cells with donor age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Mesenchymal stem cell preparations--comparing apples and oranges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Organization and maintenance of immunological memory by stroma niches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Characterisation of human bone marrow stromal cell heterogeneity for skeletal regeneration strategies using a two-stage colony assay and computational modelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Decellularized matrix from tumorigenic human mesenchymal stem cells promotes neovascularization with galectin-1 dependent endothelial interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Fibroblast growth factor 2 (Fgf2) inhibits differentiation of mesenchymal stem cells by inducing Twist2 and Spry4, blocking extracellular regulated kinase activation, and altering Fgf receptor expression levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

Insulin-Like Growth Factor-1 Sustains Stem Cell Mediated Renal Repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261879

21 January 2018

Identifiers

DOI

10.1007/BF03261879

1 reference

3 September 2017

1 reference